Next Article in Journal
Humoral and Cellular Response Induced by Primary Series and Booster Doses of mRNA Coronavirus Disease 2019 Vaccine in Patients with Cardiovascular Disease: A Longitudinal Study
Previous Article in Journal
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study
Previous Article in Special Issue
Flow Cytometry-Based Measurement of Antibodies Specific for Cell Surface-Expressed Folded SARS-CoV-2 Receptor-Binding Domains
 
 
Article

Article Versions Notes

Vaccines 2024, 12(7), 785; https://doi.org/10.3390/vaccines12070785 (registering DOI)
Action Date Notes Link
article xml file uploaded 17 July 2024 10:57 CEST Original file -
article xml uploaded. 17 July 2024 10:57 CEST Update -
article pdf uploaded. 17 July 2024 10:57 CEST Version of Record https://www.mdpi.com/2076-393X/12/7/785/pdf-vor
article html file updated 17 July 2024 11:02 CEST Original file -
article xml file uploaded 19 July 2024 06:23 CEST Update -
article xml uploaded. 19 July 2024 06:23 CEST Update https://www.mdpi.com/2076-393X/12/7/785/xml
article pdf uploaded. 19 July 2024 06:23 CEST Updated version of record https://www.mdpi.com/2076-393X/12/7/785/pdf
article html file updated 19 July 2024 06:24 CEST Update https://www.mdpi.com/2076-393X/12/7/785/html
Back to TopTop